Commonwealth Pain Specialists offers treatment with CTT’s Calmare Pain Therapy device
Competitive Technologies, Inc.
Go here to read the rest:
Commonwealth Pain Specialists offers treatment with CTT’s Calmare Pain Therapy device
Competitive Technologies, Inc.
Go here to read the rest:
Commonwealth Pain Specialists offers treatment with CTT’s Calmare Pain Therapy device
Competitive Technologies, Inc. announced today that the Department of Veterans Affairs’ Federal Supply Schedule Service has accepted CTT’s application to be an approved vendor for its Calmare® Pain Therapy Treatment
See original here:
VA Federal Supply Schedule Service approves CTT as vendor for Calmare Pain Therapy Treatment
Competitive Technologies, Inc. announced today that the Walter Reed Army Medical Center in Washington, D.C., has joined the growing list of organizations that will treat pain patients with CTT’s Calmare Pain Therapy Treatment, as authorized by the Surgeon General of the U.S. Army and Commanding General of the U.S
Follow this link:
Walter Reed Army Medical Center to treat pain patients with CTT’s Calmare Pain Therapy Treatment
IRVINE, Calif.—-Interventional Spine, Inc.
See more here:
Interventional Spine, Inc. Announces Issuance of Key Patents
Paradigm Spine, LLC, a developer of innovative non-fusion and fusion spinal implant solutions, announced today that it has completed patient enrollment in an Investigational Device Exemption pivotal clinical study comparing the coflex® interlaminar technology to instrumented posterolateral fusion in the surgical treatment of spinal stenosis.
See original here:
Enrollment complete in Paradigm Spine’s comparative study of coflex interlaminar technology
NEW YORK—-Paradigm Spine, LLC, a developer of innovative non-fusion and fusion spinal implant solutions, announced today that it has completed patient enrollment in an Investigational Device Exemption pivotal clinical study comparing the coflex® interlaminar technology to instrumented posterolateral fusion in the surgical treatment of spinal stenosis.
View original post here:
Paradigm Spine Completes Enrollment in Pivotal Clinical Study of coflex® Interlaminar Technology (Business Wire via Yahoo! Finance)
CARLSBAD, Calif. — Alphatec Holdings, Inc.
Read the rest here:
Alphatec Spine Announces Stockholder Approval of Share Issuance Related to the Acquisition of Scient’x Groupe SAS (GlobeNewswire via Yahoo! Finance)
CARLSBAD, Calif. — Alphatec Holdings, Inc. , the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that the Hart-Scott-Rodino review period for Alphatec Spine’s proposed acquisition of Scient’x …
CARLSBAD, Calif. — Alphatec Holdings, Inc. , the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today financial results for the fourth quarter and full year December 31, 2009.
Originally posted here:
Alphatec Spine Announces Fourth Quarter and Full Year 2009 Revenue and Financial Results (GlobeNewswire via Yahoo! Finance)
SRI International, an independent nonprofit research and development institute, announced today that Thomas S. Kilduff, Ph.D., director of SRI International’s Center for Neuroscience, has been named a Fellow of the American Association for the Advancement of Science (AAAS).
Read more from the original source:
Thomas S. Kilduff named a Fellow of the AAAS (News-Medical-Net)